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Summary
Background: Thoracic sarcomas are rare, and resection can leave behind defects that require
signiﬁcant reconstruction by the multidisciplinary surgical team. The aim of this study is to
review the experience of our regional referral centre with primary thoracic tumor resection
and thoracic reconstruction.
Methods: We have reviewed the treatment of all chest wall tumors resected at Sir Charles
Gairdner Hospital in Western Australia over a 5-year period. There were 11 cases in total that
involved removal of deep muscle, ribs and/or sternum.
Results: In the six cases that required bony resection, the surgical team utilized a Gore-Tex (e-
PTFE) mesh prosthesis to allow immediate closure of the defect, whilst ﬁve other closures were
achievable using primary layered closure alone. Four patients had postoperative complications,
including one who required prosthesis removal. Mean length of hospital stay was 5 days. No 30-
day or 6-month mortality was recorded. All patients were followed-up for a minimum of 24
months, and all patients were alive and free of disease at their most recent follow-up.
Conclusions: This study concurs with previous literature indicating that thoracic tumor resec-
tion and immediate reconstruction often involving use of prosthetic mesh is a safe and effective
one stage surgical procedure for a variety of chest wall defects with low postoperative morbid-
ity.
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ntroduction
rimary thoracic sarcomas represent less than 1% of all can-
ers [1], whilst only 8—10% of bony and soft tissue tumors
nd less than 10% of all sarcomas arise in the chest wall
2,3]. This makes tumor resection from the chest wall an
ncommon procedure. En-bloc wide local excision followed
y reconstruction of the remnant defect is an effective
reatment for these tumors and can often be a curative pro-
edure [2—6]. Chest wall tumors only have a short distance
efore they inﬁltrate all external chest layers, hence a large
esection is required to ensure a clear margin [7]. However
his leads to large defects that are often difﬁcult to close.
dvances in reconstructive techniques including use of pros-
hetic mesh to close defects has allowed successful excision
f tumors that would have otherwise prevented an attempt
t curative surgery with clear margins.
A collaborative approach using various surgical specialty
kill sets is an important part of this surgery [8]. This
equires a multidisciplinary approach for the assessment of
he pathology, planning of neo-adjuvant therapy, consid-
ration of surgery, and consequently will often require a
ollaborative approach in the recovery stage as well.
Chest wall tumor resection and reconstruction may be
echnically difﬁcult surgery for the tumor/thoracic sur-
eon as well as the reconstructive surgeon. Reconstruction
echniques using prosthetic mesh can facilitate closure of
arge wounds that would have otherwise prevented sur-
ical resection. This paper reviews our experience of a
ultidisciplinary approach to the treatment, surgery and
econstruction of chest wall tumors.
atients and methods
retrospective review of all patients operated on at Sir
harles Gairdner Hospital, Perth, Western Australia over a
ve-year period from 2001 through to 2006 was conducted to
dentify patients that underwent chest wall tumor resection
nd thoracic reconstruction.
The following criteria for entry into the study were used.
he only one-inclusion criteria was primary malignant chest
all tumor requiring surgical resection. Exclusion Criteria
ere:
primary or metastatic carcinoma of the lung;
lesion not requiring/amenable to resection;
thoracic spine involvement.
Included in our study were patients with tumors arising
rom bone and cartilage as well as soft tissue.
Notes and charts were reviewed for demographic details,
athology and stage, type and duration of surgery, type
f reconstruction, length of stay, prognosis, relevant
omplications, morbidity and mortality.
We aimed to assess tumor resection and reconstruction
echniques. The variables assessed included:type and location of tumor;
operating team;
length of hospital stay;
resected chest wall structures;
l
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post-op complications;
mortality, current follow up;
use of prosthetic ‘‘Gore-Tex’’ mesh as part of wound clo-
sure.
reoperative assessment
ll patients were initially assessed by orthopaedic oncol-
gy/thoracic/plastic surgery specialists, and tumors were
taged using CT, MRI, and where indicated PET. Tissue diag-
osis was obtained to aid surgical/multidisciplinary planning
n all cases prior to deﬁnitive management. This was nor-
ally by CT guided needle or core biopsy. Non-excisional
iopsy has been previous discouraged due to the possibility
f seeding of tumor and contamination of remnant tissue at
iopsy [2,7]. In our group the biopsy tract location is planned
t the Multidisciplinary Team Meeting (MDTM) so that it will
e removed at time of deﬁnitive surgery, hence less inva-
ive non excisional techniques are usually appropriate and
ffective. However open excisional biopsy is performed if CT
uided biopsy fails or is considered inappropriate. All cases
ere discussed pre-operatively at the MDTMwith the operat-
ng surgeons, pathologists, oncologists, and radiotherapists
o decide on appropriate treatment. Referral to a respi-
atory physician was made for assessment of pulmonary
unction, whilst an anesthetic review was conducted pre-
peratively to judge ﬁtness for surgery.
urgery
ll procedures were performed under general anesthe-
ia with local blocks/regional anaesthetic techniques
ependent upon tumor location (Table 1). Double lumen
ndobronchial tubes were inserted if lung involvement was
xpected or if the tumor size and location required. Antibi-
tic prophylaxis was given on induction usually with a
st generation cephalosporin, and for three postoperative
oses.
En-bloc resection was performed by orthopedic oncologi-
al and thoracic surgeons± general surgeons if the neck root
as involved. Plastic surgeons were involved in the larger
econstruction cases, focusing on the planning of incisions
nd achieving ﬁnal closure, so as to optimize the functional
nd cosmetic results.
rosthetic mesh
o allow immediate closure of the large defect in patients
equiring rib resection, the team utilized a Gore-Tex 2mm
ualMesh (GDM) ePTFE prosthesis (W.L. Gore & Assoc,
lagstaff, Arizona). This mesh has a 2-surface design that
llows reduced tissue attachment on its closed surface and
mproved tissue attachment to its macroporous surface. The
esh was sutured under tension to the surrounding chest
all structures to replace the skeleton’s stability. We usearge diameter non absorbable monoﬁlament suture (0 Pro-
ene), placed either through or around ribs, as described
reviously [9]. When extra stability is required, we com-
ined the GDM with a more rigid Dynamic Titanium Mesh
nd ligature wire (Stryker, Kalamazoo, MI).
M
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Table 1 Demographic, diagnostic and surgical data.
Case Sex Age Stage Diagnosis Defect size Team LoS Recon Resected
Structures
Margins Adjuvant Therapy Complications Follow Up
SG F 63 IA Myxoid sarcoma Left
scapular/Posterior
chest
— O 1
2
Layers Nil Marginal
Wide (<1mm)
Adjuvant
radiotherapy
Initial marginal
excision
→Revision
(sarcoma)
83 months
Disease free
GM M 85 IA Chondrosarcoma
Right anterior
Chest
80× 65mm O
C
8 GDM (1) 2nd 3rd Ribs
Right
Sternum
Marginal 1mm
(Pleural margin)
Nil Nil 25 months
Disease free
BW M 40 IB Fibromatosis/Fibromycosarcoma
Left anterior chest
— O
C
7 GDM (2) 7th 8th 9th Ribs,
abdominal wall
muscles
Intra-lesional Neo-adjuvant
radiotherapy
Chemotherapy
Nil 24 month
Disease free
AB M 38 IB Amyloidoma (with
underlying
plasmacytoma)
Sternum
170× 140mm C
O
Pl
G
9
25
GDM (2)
TitM
4.5 Ribs
bilaterally
Sternum
Intra-lesional Nil Wound
Infection/ICU
Mesh removed
Treated with
pedicled
latissimus dorsi
ﬂap
24 months
Disease free
JC F 26 IB Osteogenic sarcoma
(osteoblastoma like)
Left anterior chest
70× 140mm O 7 GDM (1) 3rd-6th Ribs left,
wedge
Left upper lobe
Wide (> 5mm) Neo-adjuvant
Chemotherapy
Adjuvant
Chemotherapy
Atrial thrombus
successfully
treated with
enoxaparin
41 months
Disease free
DD M 77 IIA Dedifferentiated
liposarcoma
Right lateral
Chest/Axilla
- O 4 Layers Pectoralis
Major/Minor
Wide (6mm) Adjuvant
Radiotherapy
Nil 57 months
Disease free
SM M 76 IIA Malignant Fibrous
Histiocytoma
Right posterior
Chest (subscapular)
— O 4 Layers Latissimus dorsi
Scapula tip
Marginal Neo-adjuvant
radiotherapy
Adjuvant
radiotherapy
Infected seroma
successfully
treated IVAb’s
66 months
Disease free
PC M 24 IIA PNET: Left
Anterior chest
— O 3 Layers Nil Wide (6.5mm) Neo-Adjuvant
chemotherapy
Adjuvant
chemotherapy
Nil 24 months
Disease free
JH M 67 IIB Spindle cell sarcoma
Right anterior chest
— O —
2
2
Layers Pectoralis Major Marginal (deep)
Wide (0.3mm deep)
Radical Adjuvant
Radiotherapy
(positive margins)
Not our unit
Revision →still
positive margins
Recurrence
30 months
Disease free
WC M 67 IIB Chondrosarcoma
Right anterior
Chest/Axilla
150× 90mm OC 7 GDM (1) 4th—6th Ribs
Bilaterally
Marginal (pleural
margin)
Rest > 5mm
Nil Nil 25 months
Disease free
SB F 82 IIB Ossifying ﬁbromyxoid
sarcoma
Right anterior chest
130× 105mm OC 6 GDM (1) 3.5 Ribs on Right Marginal (pleural
margin)
Rest ∼1mm
Nil Nil 24 months
Disease free
Staging system: Enneking et al. [11]; follow-up: includes time since surgery, status of disease; age: as at 2009; team: O: orthopedics; C: cardiothoracics; Pl: plastics; G: general surgery;
LoS: length of stay (days), multiple numbers indicate LoS in subsequent admissions; Recon: type of reconstruction; GDM: gore-tex dual mesh; TitM: titanium mesh; number in parentheses
indicates quantity of mesh used
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ostoperative care
atients were nursed on the general orthopedic ward, but
ad access to a high dependency or intensive care unit
f deemed necessary intra-operatively or in the recovery
oom. Patients were reviewed on the ward by all specialties
nvolved in their care.
All patients were followed up in the orthopedic oncology
linic after discharge. Follow up occurred 3 monthly for the
rst 2 years, then 6 monthly up to 5 years with an ultrasound
f the local area and CXR conducted at these intervals. In
ddition at 1 and 2 years a local MRI or CT scan± a PET scan
as performed.
esults
emographics
leven patients were included in the study (Table 1).
here were eight males. The age range at time of surgery
as 22—82years, with no children encountered during this
eriod. Eight patients (73%) had tumors located predomi-
antly in the anterior chest wall, two (18%) were posterior
nd one (9%) was located laterally. Follow up ranged from
4—83 months.
athology
ll but one diagnosis was for subtypes of sarcoma (10
atients — 92%). One patient had a primary amyloidoma.
ll were primary tumors. Associated treatment and plan-
ing including neo-adjuvant and adjuvant radiotherapy
nd/or chemotherapy. Treatment regimens were deter-
ined at the MDTM with the entire multidisciplinary
eam present. A number of different therapy combinations
ere used in our study, and were tailored to the stage,
rade, age and co-morbidities of each patient (Table 1).
wo patients received neo-adjuvant radiotherapy and four
atients received neo-adjuvant chemotherapy, while four
atients underwent adjuvant radiotherapy with two receiv-
ng adjuvant chemotherapy. Five patients did not require
on-surgical therapy.
urgery
ach patient had tumors resected from their chest walls
ncluding removal of deepmuscle, ribs and or sternumwhere
ndicated to achieve an appropriate margin. Five cases were
perated on solely by the Orthopedic Team, and these cases
nvolved only soft tissue resection, allowing simple primary
ayered closure. The other six cases involved signiﬁcant
esection of ribs or sternum and involved combined oper-
tive teams including orthopedics, cardiothoracics, general
nd plastic surgery. The mean size of chest wall defect that
ecessitated closure with Gore-Tex mesh in our study was
1.36 cm2 (Table 1).
Where rib resection was required, the surgical team
ended to dissect one rib space above and below the
acroscopic appearance of the tumor, but when in doubt
rozen sections were taken intraoperatively and analyzed to
a
m
z
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ndicate adequacy of resection. Lung wedge resection was
erformed in one case (JC) due to tumor presence in the
leura at frozen section.
ostoperative outcomes
ll patients had routine peri-operative care at primary oper-
tion. Mean length of hospital stay of primary operation was
ust over 5 days. For patients requiring mesh to close signif-
cant chest wall defects, this increased to 7.4 days. No 30
ay or 6 month mortality was recorded.
Four patients had postoperative complications. Two
equired reexcisions, one of whom was for incomplete mar-
ins where initial benign biopsy proved incorrect, and the
ther was for recurrence in a patient who had been referred
o our unit with a previous marginal resection. One patient
eveloped a seroma and superﬁcial wound infection that was
uccessfully treated with oral antibiotics. One patient (AB)
eveloped a deep wound infection that progressed to sep-
is and required wound washout and prosthesis removal. This
atient required ICU admission after their second operation.
his patient had a complete recovery with their defect later
losed with a pedicled latissimus dorsi ﬂap [10].
At time of most recent review (24—83 months) disease
ree and overall survival was 100%.
iscussion
urvival after resection and reconstruction for chest wall
umors is dependent on a number of factors including the
nitial staging of the disease, presence of metastasis and
argins of resection [6,12]. Despite sensitivity to radiother-
py and occasionally chemotherapy, bony and soft tissue
arcomas usually require surgery, with en-bloc wide local
xcision offering the best chance of cure. Reconstruction
sing synthetic mesh allows defects of signiﬁcant dimen-
ions to be closed, meaning large tumor size or involvement
f bony structures should not technically limit resection
ptions [13].
Positive margins in sarcoma surgery have been shown
o be detrimental to rates of recurrence [14,15]. Absence
f recurrence is a major factor in improving disease free
nd overall survival hence the importance of a clear mar-
in in potentially curative surgery [13]. Although staging
f musculoskeletal tumors has generally accepted crite-
ia as deﬁned by the surgical staging of musculoskeletal
arcoma [11] what constitutes a safe margin in sarcoma
urgery has generated controversy within the literature and
s not clearly deﬁned. Some studies have advocated a radi-
al resection with macroscopic margins of greater than 4 cm
12,16]. Overall recurrence and survival rates may improve
ith wider margins but a minimum uncontaminated mar-
in to achieve local control has been reported to be as
ittle as 1mm, with the presence of clear margins-even
f 1mm-correlating with satisfactory outcomes in terms of
ecurrence [15].A wide excision involves clear margins throughout with
rim of normal tissue as part of the dissection, a
arginal resection has a margin that transposes the reactive
one whilst an intralesional resection involves a dissection
hrough the tumor itself [11]. In our series the type of
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margin desired and accepted depended on the grade and
type of tumor as well as factors relating to the health of
the patient. Two patients in our study had re-excision as
the initial marginal resection was considered unacceptable.
In one of these (SB) biopsy had indicated benign myxoma
however ﬁnal histopathology showed myxoma, whilst the
other patient had been initially incompletely excised at
another secondary hospital. It is important to note that
in three patients tumors that reached and/or projected
from the internal aspect of the chest wall were labeled as
marginal resections despite complete tumor excision. This
was because the parietal pleura is in direct contact with this
area and hence a wide margin cannot be formally deﬁned
as there is no rim of normal tissue between the structures.
In each of these patients it was not felt to be necessary
to undertake a wedge resection of nearby lung so as to
enable formal achievement of a wide margin as both tumors
appeared to be macroscopically encapsulated and had neg-
ative frozen sections taken at time of surgery. Each of these
patients remain disease free at most recent follow-up.
Our recorded margins have lead to satisfactory patient
outcomes as we recorded only 1 case of recurrence (9%)
in our series, and this was in the patient from another
institution who we had re-excised. Notwithstanding the
small sample, we have recorded no deaths in this series of
patients, whilst every patient in the study is disease free at
their most recent follow-up (24—83 months) (Table 1).
All but 1 case of malignant primary chest wall tumor in
our series was a sarcoma. Histopathology on the remaining
patient (AB) showed a thoracic amyloidoma, a deposit of
amyloid, which behaves as a low-grade malignancy. This is
an extremely rare tumor, with only two other cases reported
in the literature [17,18].
A number of previous studies have described use of soft
prosthetic mesh in chest wall reconstruction, including Mar-
lex (Bard Implants, Billerica Mass.) and Prolene (Ethicon Inc,
Somerville NJ) while more rigid composites utilizing methyl
methacrylates have also been described [3,19—22]. A soft
Gore-Tex DuelMesh (ePTFE) has been used in our cases if the
defect is large or includes bony structures. Where greater
than four ribs and the entire sternum are resected, we
combine this with a more rigid titanium mesh and wire to
improve stability and help prevent paradoxical respiratory
movements. Chest wall reconstruction using Gore-Tex ePTFE
has been previously described in the literature, and is often
favored due to its increased ability to be sutured, stretched
and molded into wounds as well as its more impermeable
nature [8]. Results from studies using ePTFE show good func-
tional and aesthetic outcomes as well as low infection rates
[9,16,23,24], while PTFE also has a theoretical advantage in
its ability to form a watertight seal of the pleural space [9].
The literature has described wound infection rates of
5% following chest wall tumor resection and reconstruction
[9,19,20]. There has been no evidence that any particular
type of prosthetic mesh is associated with lower infection
rates [9]. Our series recorded one case of superﬁcial wound
infection and one deep wound infection requiring mesh
removal, though an infection rate is not comparable due
to the small numbers in the study.
Mean length of stay was increased in patients requiring
mesh for reconstruction, indicating their large, bony chest
wall defect and need for greater recuperation. However
C
T
d77
ength of stay for patients requiring mesh and overall was
ess in our series than has been reported previously [25].
Overall morbidity following wide chest wall resection
ith immediate reconstruction has consistently shown to
e satisfactory, and these outcomes are repeated in our
tudy [4,20,25,26]. Our study has shown no 30-day mor-
ality following this procedure, which is again consistent
ith previous series [12,25—27], while our overall survival
t 2 years is 100%. A multidisplinary approach to treat-
ent that involves both neo-adjuvant and adjuvant chemo
nd radiotherapy is likely to have contributed to these pos-
tive outcomes. Furthermore, adequate surgical resection
chieved by wide margins that are not restricted by wound
losure issues has been previously shown to prevent dis-
emination of tumor and improve survival patients with
hest wall tumours [5], results that are emphasized in our
tudy.
onclusions
his study has found that a multidisciplinary approach com-
ined with an aggressive surgical resection and defect
econstruction can contribute to satisfactory outcomes in
he treatment of chest wall tumors as measured by peri-
perative morbidity, recurrence and disease free and overall
urvival. This can be attributed to appropriate planning of
ulti pronged treatment from the earliest diagnostic phase,
ombined with the ability to resect the widest possible sur-
ical margin.
Although resection of tumors in this region with sufﬁ-
ient margins may lead to large chest wall defects, we
ave corroborated previous literature, which has found
hat primary closure of these defects can be satisfactorily
chieved in most cases. Where signiﬁcant rib or sternum
esection is required, we found that immediate closure of
hest wall defects using a dual surface, ePTFE prosthetic
esh occasionally combined with titanium mesh for rigid-
ty is a safe and effective one stage surgical procedure
or a variety of defects with low postoperative morbid-
ty.
These ﬁndings further add to the body of literature,
hich suggests that multidisciplinary management of chest
all tumors allows for best practice care of these patients.
urthermore, potentially curative surgical treatment for pri-
ary chest wall tumors should be dictated by achievement
f satisfactory surgical margins and not mitigated by size
f eventual chest wall defect or resection of associated
tructures. This may reduce the rate of recurrence and
ontribute to improved disease free and overall survival in
his group of patients. This paper has shown satisfactory
esults at a minimum 2-year follow-up. Further study of
hese patients, focusing on 5-year disease free and over-
ll survival, will be an even stronger test of these treatment
odalities.onﬂict of interest statement
he authors submit that there are no conﬂicts of interest to
eclare.
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